AI-guided treatment planning for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial uses artificial intelligence (AI) to help plan personalized treatment for esophageal cancer by combining images and tissue samples. It aims to improve care by guiding doctors to choose the best therapy for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with esophageal cancer (confirmed by biopsy).
- You must not have received any previous cancer treatment.
- You must be able to undergo an MRI (no metal implants or claustrophobia that would prevent it).
- You must be willing and able to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to create a digital twin of your cancer and simulate how it might respond to treatment. It aims to personalize your care and improve outcomes for people with locally advanced esophageal cancer.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
This study looks at whether CT and MRI scans taken before and after chemotherapy or radiation can help doctors predict how well the treatment is working and what the cancer looks like after surgery. It may help improve treatment plans for people with esophageal cancer.
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
This trial tests if artificial intelligence can help doctors more accurately determine how deep early esophageal cancer goes during an endoscopic ultrasound. It may lead to better treatment decisions for people with early signs of esophageal cancer.
This trial tests whether an artificial intelligence (AI) model can accurately predict if esophageal cancer will completely disappear after chemotherapy combined with immunotherapy before surgery. If successful, it could help doctors decide the best treatment plan for patients.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.